DR LAL PATHLABS
Back to Income Statement
|
DR LAL PATHLABS Last 5 Year Revenue History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Operating Income | ₹2,227 Cr | ₹2,017 Cr | ₹2,087 Cr | ₹1,581 Cr | ₹1,330 Cr |
What is the latest Revenue of DR LAL PATHLABS ?
| Year | Revenue |
|---|---|
| Mar2025 | ₹2,227 Cr |
| Mar2024 | ₹2,017 Cr |
| Mar2023 | ₹2,087 Cr |
| Mar2022 | ₹1,581 Cr |
| Mar2021 | ₹1,330 Cr |
How is Revenue of DR LAL PATHLABS Trending?
| Years | Revenue | % Change | |
|---|---|---|---|
| Mar2025 | ₹2,227 Cr | 10.40 | |
| Mar2024 | ₹2,017 Cr | -3.38 | |
| Mar2023 | ₹2,087 Cr | 32.01 | |
| Mar2022 | ₹1,581 Cr | 18.86 | |
| Mar2021 | ₹1,330 Cr | - | |
Compare Revenue of peers of DR LAL PATHLABS
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| DR LAL PATHLABS | ₹23,748.9 Cr | -5.7% | -1.4% | -6.3% | Stock Analytics | |
| APOLLO HOSPITALS ENTERPRISE | ₹104,381.0 Cr | 2.5% | 3.4% | -0.9% | Stock Analytics | |
| MAX HEALTHCARE INSTITUTE | ₹98,944.5 Cr | -3.2% | -5.6% | -14% | Stock Analytics | |
| FORTIS HEALTHCARE | ₹68,112.3 Cr | -1.4% | 5.8% | 24.9% | Stock Analytics | |
| NARAYANA HRUDAYALAYA | ₹38,761.1 Cr | -0.3% | 2.1% | 41.6% | Stock Analytics | |
| GLOBAL HEALTH | ₹31,628.6 Cr | -4.9% | 1.7% | 13% | Stock Analytics | |
DR LAL PATHLABS Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| DR LAL PATHLABS | -5.7% |
-1.4% |
-6.3% |
| SENSEX | -2.6% |
-1.3% |
7.2% |
You may also like the below Video Courses